Tetrandrine synergizes with MAPK inhibitors in treating KRAS-mutant pancreatic ductal adenocarcinoma via collaboratively modulating the TRAIL-death receptor axis
2024-03-14 16:20
Tetrandrine synergizes with MAPK inhibitors in treating KRAS-mutant pancreatic ductal adenocarcinoma via collaboratively modulating the TRAIL-death receptor axis
By: Tang, Shuai; Duan, Yichen; Yuan, Tao; Hu, Yuting; Yuan, Liang; Shen, Ning; Fu, Yixian; Pu, Congying; Wang, Xiaomin; Xu, Jun; et al
Pharmacological Research (2023), 197, 106955 | Language: English, Database: CAplus and MEDLINE
科研成果 
